Immix Biopharma Inc.
(IMMX)
undefined
undefined%
At close: undefined
2.14
5.42%
After-hours Dec 13, 2024, 07:49 PM EST
Cashflow (Annual)
Get detailed ratio statement breakdowns, uncovering price to
free cash flow ratio, price per earnings, and much more.
Year | FY23 | FY22 | FY21 | FY20 | FY19 |
Net Income | -15.60M | -8.23M | -24.38M | -1.15M | -972.81K |
Depreciation & Amortization | 5.47K | 2.13K | 2.47K | 2.32K | 1.08K |
Stock-Based Compensation | 2.57M | 624.07K | 218.98K | - | - |
Other Working Capital | -781.56K | -936.53K | -284.97K | 169.68K | 58.74K |
Other Non-Cash Items | - | 100.00K | 118.16K | 575.00K | -84.50K |
Deferred Income Tax | - | - | 22.85M | - | - |
Change in Working Capital | 1.65M | 195.21K | -391.04K | 165.85K | 181.70K |
Operating Cash Flow | -11.37M | -7.41M | -1.59M | -404.69K | -790.03K |
Capital Expenditures | -52.09K | - | -802 | - | -7.31K |
Acquisitions | - | - | - | - | - |
Purchase of Investments | - | - | - | - | - |
Sales Maturities Of Investments | - | - | - | - | - |
Other Investing Acitivies | - | - | -802 | - | - |
Investing Cash Flow | -52.09K | - | -802 | - | -7.31K |
Debt Repayment | - | - | 200.00K | - | 1.05M |
Common Stock Repurchased | - | -99.96K | - | - | - |
Dividend Paid | - | - | - | - | - |
Other Financial Acitivies | -229.38K | -56.72K | - | - | - |
Financial Cash Flow | 15.46M | 3.23M | 18.85M | - | 1.05M |
Net Cash Flow | 4.07M | -4.21M | 17.25M | -342.93K | 271.69K |
Free Cash Flow | -11.42M | -7.41M | -1.59M | -404.69K | -797.34K |